NSE
Anupam Rasayan India LimitedANURAS
Anupam Rasayan India Limited is a leading manufacturer of organic and inorganic chemicals, serving various industries including pharmaceuticals, agrochemicals, and water treatment.
| Key products | Organic and inorganic chemicals |
|---|---|
| Geography | India (domestic market) |
| Competitors | Hindustan Salts Limited, Indian Fine Chemicals Ltd |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Bullish
Next corporate action
Interim Dividend - Rs 0.75 Per Sh
ex 2025-07-21
Competitive landscape — the read
vs mapped peers| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ACUTAAS | +₹98.2 Cr | 1 | — | — | +4 | 6 |
| 2 | AAVAS | +₹79.7 Cr | 5 | — | — | — | — |
| 3 | ANURASThis | — | — | — | +1 | — | — |
| 4 | AADHARHFC | — | — | — | — | — | — |
| 5 | AARTIIND | +₹0 Cr | 4 | — | — | — | — |
| 6 | ACE | +₹0 Cr | 2 | — | — | — | — |
| 7 | ACMESOLAR | −₹80.9 Cr | 1 | — | — | +3 | 6 |
| 8 | ABLBL | −₹314.4 Cr | 29 | — | — | — | — |
| 9 | ABFRL | −₹730.3 Cr | 13 | — | +1 | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — ANURAS day by day
- 2026-06-11FilingAnupam Rasayan India Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled APress Release
- 2026-06-09FilingAnupam Rasayan India Limited has informed the Exchange about Draft Letter of Offer filed by the Manager to theM&A
- 2026-06-09FilingKiran Pallavi Investments LLC has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of theShareholding Disclosure
- 2026-06-09FilingKiran Pallavi Investments LLC has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of theShareholding Disclosure
- 2026-06-09FilingAnand Desai has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and ExShareholding Disclosure
- 2025-07-21ActionInterim Dividend - Rs 0.75 Per ShDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Press ReleaseNeutral
a press release dated Jun 11, 2026, titled Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"".
Source PDF → - 5M&ABullish
Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
No bulk/block deals for ANURAS in this window.
News & chatter on ANURAS
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.